The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...

Merck (MRK) and a woman suing the company have agreed to pause a trial over alleged injuries linked to its human papillomavirus vaccine, a case ...

Robert F. Kennedy Jr., in his first time addressing HHS staffers as secretary, lays out his vision for the department. Read ...

Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus ...

Moderna MRNA announced fourth-quarter 2024 results. Though earnings and sales beat estimates, both metrics declined ...

Moderna stock reversed losses on its fourth-quarter report after CEO Stephane Bancel deflected concerns over RFK Jr. Is MRNA stock a buy?

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Both are species of cowardice.” The right cared nothing for either Jennifer or Melissa, or for their mothers. Their pain only ...

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

A growing measles outbreak in west Texas has infected 48 people, according to official state data released Thursday — the ...

Moderna Inc. recorded a quarterly loss as vaccine sales waned and the company had an unexpected charge for a canceled ...